Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LAM RESEARCH CORP Director's Dealing 2023

Mar 3, 2023

29803_dirs_2023-03-03_7df2498e-1242-40a9-b142-cdad10f48a3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LAM RESEARCH CORP (LRCX)
CIK: 0000707549
Period of Report: 2023-03-01

Reporting Person: ARCHER TIMOTHY (President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-01 Common Stock A 6034 Acquired 107718 Direct
2023-03-01 Common Stock F 1321 $490.92 Disposed 106397 Direct
2023-03-01 Common Stock F 836 $490.92 Disposed 105561 Direct
2023-03-02 Common Stock F 8666 $489.98 Disposed 96895 Direct
2023-03-02 Common Stock F 2006 $489.98 Disposed 94889 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Market-based Performance Restricted Stock Unit $0.0 A 18102 Acquired Common Stock (18102.0) Direct
2023-03-01 Employee Stock Option (Right to Buy) $490.92 A 18102 Acquired 2030-03-01 Common Stock (18102.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4802.684 Indirect
Common Stock 567.098 Indirect

Footnotes

F1: The restricted stock units will vest in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.

F2: The amount reported includes shares subject to unvested restricted stock units.

F3: Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations.

F4: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.

F5: The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.